BG60764B2 - Производно на изоксазола,метод за неговото получаване и средства,съдържащи това съединение - Google Patents

Производно на изоксазола,метод за неговото получаване и средства,съдържащи това съединение Download PDF

Info

Publication number
BG60764B2
BG60764B2 BG098534A BG9853494A BG60764B2 BG 60764 B2 BG60764 B2 BG 60764B2 BG 098534 A BG098534 A BG 098534A BG 9853494 A BG9853494 A BG 9853494A BG 60764 B2 BG60764 B2 BG 60764B2
Authority
BG
Bulgaria
Prior art keywords
formula
acid
compound
carboxylic acid
methylisoxazole
Prior art date
Application number
BG098534A
Other languages
Bulgarian (bg)
English (en)
Inventor
Friedrich-Johan Kaemmerer
Rudolf Schleyerbach
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of BG60764B2 publication Critical patent/BG60764B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Lubricants (AREA)
BG098534A 1978-12-16 1994-02-23 Производно на изоксазола,метод за неговото получаване и средства,съдържащи това съединение BG60764B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782854439 DE2854439A1 (de) 1978-12-16 1978-12-16 Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung

Publications (1)

Publication Number Publication Date
BG60764B2 true BG60764B2 (bg) 1996-02-29

Family

ID=6057414

Family Applications (1)

Application Number Title Priority Date Filing Date
BG098534A BG60764B2 (bg) 1978-12-16 1994-02-23 Производно на изоксазола,метод за неговото получаване и средства,съдържащи това съединение

Country Status (25)

Country Link
US (2) US4284786A (lt)
EP (1) EP0013376B1 (lt)
JP (1) JPS5583767A (lt)
AR (2) AR222680A1 (lt)
AT (1) ATE1067T1 (lt)
AU (1) AU529341B2 (lt)
BG (1) BG60764B2 (lt)
CA (1) CA1129867A (lt)
DE (2) DE2854439A1 (lt)
DK (1) DK149886C (lt)
EG (1) EG13926A (lt)
ES (2) ES486758A1 (lt)
FI (1) FI64154C (lt)
GR (1) GR72731B (lt)
HU (1) HU178015B (lt)
IE (1) IE49126B1 (lt)
IL (1) IL58951A (lt)
LU (1) LU90466I2 (lt)
MX (2) MX6174E (lt)
NL (1) NL990037I2 (lt)
NO (1) NO148925C (lt)
NZ (1) NZ192400A (lt)
PH (1) PH16627A (lt)
PT (1) PT70596A (lt)
ZA (1) ZA796793B (lt)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3247454A1 (de) * 1982-12-22 1984-06-28 Laboratorios Bago S.A., Buenos Aires Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2538806B1 (fr) * 1982-12-30 1986-02-21 Bago Sa Labor Composes phenyl-3 methyl isoxazole-5 carboxy-4 anilides substitues, actifs therapeutiquement contre l'inflammation et la douleur
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
US4935434A (en) * 1988-01-26 1990-06-19 Bristol-Myers Company Antiarthritic isoxazole-4-carboxamides
FR2662692B1 (fr) * 1990-05-30 1995-04-28 Novapharme Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
US5258397A (en) * 1988-11-30 1993-11-02 Novapharme 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
DD297328A5 (de) 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
US5108999A (en) * 1990-02-02 1992-04-28 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
RU2142937C1 (ru) * 1990-05-18 1999-12-20 Хехст АГ Амиды органических кислот, способ их получения и фармацевтическая композиция
DE4127737A1 (de) 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
US6133301A (en) * 1991-08-22 2000-10-17 Aventis Pharma Deutschland Gmbh Pharmaceuticals for the treatment of rejection reactions in organ transplantations
ES2124801T3 (es) * 1993-01-08 1999-02-16 Hoechst Ag Empleo de leflunomida para la inhibicion del factor de necrosis de tumores alfa.
EP0607775B1 (de) * 1993-01-08 1998-12-09 Hoechst Aktiengesellschaft Verwendung von Leflunomid zur Hemmung von Interleukin 1 beta
DK0607777T3 (da) * 1993-01-08 1999-08-16 Hoechst Ag Anvendelse af leflunomid til inhibering af interleukin 8
ES2124799T3 (es) * 1993-01-08 1999-02-16 Hoechst Ag Empleo de leflunomida para la inhibicion de interleuquina 1 alfa.
TW314467B (lt) * 1993-03-31 1997-09-01 Hoechst Ag
DE4323636A1 (de) * 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
LT3589B (en) 1993-11-30 1995-12-27 Hoechst Ag Using of known combination for treatment of rejection reaction by transplantation of organs
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
US5624946A (en) * 1994-07-05 1997-04-29 Williams; James Use of leflunomide to control and reverse chronic allograft rejection
CA2202904C (en) * 1994-10-17 2006-12-19 Yukio Amano Pharmaceutical composition for prophylaxis and treatment of type i allergic diseases
US5721277A (en) * 1995-04-21 1998-02-24 Sugen, Inc. Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19702988A1 (de) * 1997-01-28 1998-07-30 Hoechst Ag Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
DK0987256T3 (da) * 1997-08-08 2002-02-11 Aventis Pharma Gmbh Krystalform af N-(4-trifluormethylphenyl)-5-methylisoxazol-4-carboxylsyreamid
US7691890B2 (en) 1998-03-11 2010-04-06 James W. Williams Anti-viral uses of leflunomide products
US20050255071A1 (en) * 1998-12-10 2005-11-17 Aventis Pharma Deutschland Gmbh Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors
DE19908527C2 (de) * 1999-02-26 2001-08-30 Aventis Pharma Gmbh Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid
US6566395B1 (en) 1999-05-25 2003-05-20 Biomedicines, Inc. Methods of treating proliferative disorders
DE19960443C2 (de) * 1999-12-15 2002-05-08 Aventis Pharma Gmbh Verfahren zur Auffindung von Nukleotidsyntheseinhibitoren mit weniger Nebenwirkungen
IL149792A0 (en) * 1999-12-16 2002-11-10 Teva Pharma Novel processes for making and a new crystalline form of leflunomide
ES2237553T3 (es) 2000-02-15 2005-08-01 Teva Pharmaceutical Industries Ltd. Procedimiento para la sintesis de leflunomida.
EP1473035A1 (en) * 2000-02-15 2004-11-03 Teva Pharmaceutical Industries Ltd. Leflunomide of high purity
AU2001284891A1 (en) * 2000-08-14 2002-02-25 Teva Pharmaceutical Industries Ltd. Micronized leflunomide
PT1381356E (pt) 2001-04-05 2008-07-24 Aventis Pharma Inc Utilização de (4' -trifluorometilfenil) - amida do ácido (z) -2- ciano-3-hidroxi-but-2-enóico para tratamento da esclerose múltipla
GB0123571D0 (en) 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
US20030139606A1 (en) * 2001-11-09 2003-07-24 Ray Anup Kumar Process for preparing 5-methylisoxazole-4-carboxylic- (4'-trifluoromethyl)-anilide
US20050158371A1 (en) * 2002-02-12 2005-07-21 Sumitomo Pharmaceuticals Co., Ltd. Novel external agent
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
US20060024376A1 (en) * 2004-07-30 2006-02-02 The University Of Chicago Methods and compositions for reducing toxicity associated with leflunomide treatment
WO2007026737A1 (ja) * 2005-08-31 2007-03-08 Kowa Co., Ltd. 関節リウマチの予防及び／又は治療法
EP2125895B1 (en) * 2007-02-02 2015-04-08 Vegenics Pty Ltd Vegf receptor antagonists for treating organ transplant alloimmunity and arteriosclerosis
CN101817797B (zh) * 2009-02-26 2013-04-10 江苏亚邦爱普森药业有限公司 高纯度3-甲基-n-[4-(三氟甲基)苯基]-4-异噁唑甲酰胺的合成方法
US9205577B2 (en) * 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
US11202853B2 (en) * 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses
JOP20190207A1 (ar) 2017-03-14 2019-09-10 Actelion Pharmaceuticals Ltd تركيبة صيدلانية تشتمل على بونيسيمود
JP2021519334A (ja) 2018-03-26 2021-08-10 クリア クリーク バイオ， インコーポレイテッド ジヒドロオロト酸デヒドロゲナーゼを阻害するための組成物および方法
WO2021013815A1 (en) 2019-07-22 2021-01-28 Actelion Pharmaceuticals Ltd Methods of treating multiple sclerosis
BR112022017754A2 (pt) 2020-03-06 2022-10-18 Actelion Pharmaceuticals Ltd Métodos para retardar a perda de volume cerebral
US20210300873A1 (en) 2020-03-20 2021-09-30 Clear Creek Bio, Inc. Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof
CA3220684A1 (en) 2021-10-11 2023-04-20 Actelion Pharmaceuticals Ltd Methods of treating multiple sclerosis
WO2023062511A1 (en) * 2021-10-11 2023-04-20 Actelion Pharmaceuticals Ltd Methods of treating multiple sclerosis
WO2023152290A1 (en) 2022-02-11 2023-08-17 Actelion Pharmaceuticals Ltd Methods of slowing an increase in brain ventricular volume

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087534A (en) * 1974-05-22 1978-05-02 David Ovadia N-haloalkylmio urazole pesticides
DE2524959C2 (de) * 1975-06-05 1983-02-10 Hoechst Ag, 6000 Frankfurt 5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel
ES448386A1 (es) * 1975-06-05 1978-04-16 Hoechst Ag Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico.
DE2654797A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Verfahren zur herstellung von isoxazolderivaten

Also Published As

Publication number Publication date
NO148925B (no) 1983-10-03
IL58951A (en) 1984-01-31
FI64154B (fi) 1983-06-30
US4351841A (en) 1982-09-28
ES486758A1 (es) 1980-05-16
MX6174E (es) 1984-12-04
ATE1067T1 (de) 1982-06-15
EP0013376A3 (en) 1980-09-17
IL58951A0 (en) 1980-03-31
ES486750A1 (es) 1980-06-16
FI793899A7 (fi) 1980-06-17
EG13926A (en) 1982-09-30
DK149886C (da) 1987-04-21
ZA796793B (en) 1980-11-26
DE2962929D1 (en) 1982-07-08
LU90466I2 (fr) 2000-01-03
EP0013376A2 (de) 1980-07-23
AR226894A1 (es) 1982-08-31
CA1129867A (en) 1982-08-17
MX8403A (es) 1994-03-31
IE49126B1 (en) 1985-08-07
AR222680A1 (es) 1981-06-15
DE2854439A1 (de) 1980-07-03
DK534279A (da) 1980-06-17
NL990037I1 (nl) 2000-01-03
NO148925C (no) 1984-01-11
DK149886B (da) 1986-10-20
EP0013376B1 (de) 1982-05-19
NZ192400A (en) 1982-02-23
NO794094L (no) 1980-06-17
PH16627A (en) 1983-12-05
NL990037I2 (nl) 2000-01-03
JPS5583767A (en) 1980-06-24
HU178015B (en) 1982-02-28
GR72731B (lt) 1983-12-01
AU529341B2 (en) 1983-06-02
IE792426L (en) 1980-06-16
PT70596A (de) 1980-01-01
US4284786A (en) 1981-08-18
FI64154C (fi) 1983-10-10
JPH0133470B2 (lt) 1989-07-13
AU5385379A (en) 1980-06-19

Similar Documents

Publication Publication Date Title
BG60764B2 (bg) Производно на изоксазола,метод за неговото получаване и средства,съдържащи това съединение
US4476137A (en) [1-(2-Benzoxazolyl)hydrazino]alkyl nitrile derivatives
HUT60479A (en) Process for producing 4-isoxazole carboxamide derivatives and pharmaceutical compositions comprising such active ingredient
EP0116639A1 (en) Acyl guanidines
SU1080745A3 (ru) Способ получени производных тетразола
JPS58219161A (ja) １，３−ジヒドロ−４−（１−ヒドロキシ−２−アミノエチル）−２ｈ−インド−ル−２−オンの新誘導体、それらの塩類、それらの製造法、薬剤としての使用及びこれらを含有する組成物
US4636513A (en) Isoxazole derivatives and medicaments containing these compounds
US4272507A (en) Phenylaminothiophenacetic acids, their synthesis, compositions and use
US4307113A (en) Anthranilic acid derivatives
EP0099122B1 (en) Compositions comprising pepstatin and an histamine h2-receptor antagonist having an enhanced antiulcer activity
KR840000705B1 (ko) 신규 피리미딘 유도체의 제조방법
US4511574A (en) N-(4-Phenyl-2-thiazolyl)carbamate derivatives
KR820002229B1 (ko) 이속사졸 유도체의 제조방법
US3985880A (en) 2-(R'-oxymethyl)-perimidines
EP0440324A2 (en) Substituted beta-diketones and their use
US3767811A (en) Glyceryl n substituted phenyl anthranilates in the treatment of inflammation
US4333938A (en) Imino derivatives of 5-aminobenzodioxole-1,3 which are useful as medicaments
US4156009A (en) Diazepine derivatives
KR870001223B1 (ko) 이속사졸 유도체의 제조방법
HU182916B (en) Process for preparing 1,3-benzoxazine-2,4-dione derivatives
US4565888A (en) Substituted salicylic acid amide anthelmintics
US4440786A (en) Compounds with antiinflammatory and analgesic activity, process for the preparation thereof and pharmaceutical compositio ns therefrom
US4061771A (en) Ethynylindenyl compounds and derivatives thereof used in the treatment of pain, fever and inflammation
HU211020B (en) Process for producing new phenylsulphonyl acrylic acid derivatives and pharmaceutical compositions containing the same
JPS62209060A (ja) ピロロ安息香酸誘導体